Search results
3 Magnificent Stocks That Are Passive Income Machines
Motley Fool via Yahoo Finance· 23 hours agoNovartis is a dependable growth stock with a high yield David Jagielski (Novartis): One healthcare...
Novartis Gets FDA Breakthrough Therapy Designation for Scemblix
Morningstar· 5 days agoNovartis said the U.S. drug regulator decided to expedite the development of Scemblix, to treat adults newly diagnosed with leukemia. The Swiss pharmaceutical< ...
Exploring Dividend Stocks In Switzerland With Compagnie Financière Tradition And Two Others
Simply Wall St. via Yahoo Finance· 1 day agoSwiss stocks showed modest gains in a recent trading session, reflecting cautious investor sentiment...
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...
The Hill via Yahoo Finance· 7 days agoA new report from the center-left watchdog group Accountable US found that most major drugmakers...
TFF Pharmaceuticals (NASDAQ:TFFP) vs. Alnylam Pharmaceuticals (NASDAQ:ALNY) Financial Contrast
ETF DAILY NEWS· 5 days agoAlnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) and TFF Pharmaceuticals (NASDAQ:TFFP – Get Free Report) are both medical companies, but which is ...
Q1 2024 Harrow Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 hours agoWe are firmly back on track with our historical growth trajectory over the last several years of low double digit growth in this business. Our balance sheet continues to be solid, with $76 million ...
UK pharma giants pledge £430m investment in France after Macron charm offensive
The Telegraph via Yahoo Finance· 2 days agoAstraZeneca...country. Investment from the FTSE giants will coincide with an additional €500m from...
Brain waste: College-educated adult immigrants struggle to work in their fields in the U.S.
WLRN Miami· 6 days agoClaudia Londoño recalls her first job in the United States in 2021. At that moment, memories of the years she spent earning her bachelor’s and master’s degrees flooded her mind. Londoño is a ...
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
Zacks via Yahoo Finance· 7 days agoZacks Rank Ionis currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks...
Earnings call: Harrow Inc. reports robust revenue growth in Q1 2024 By Investing.com
Investing.com· 15 hours agoHarrow, Inc. (ticker not provided), a prominent player in the ophthalmic pharmaceuticals industry,...
